A Case of Non-Small Cell Lung Cancer (NSCLC) with Oligoprogressive Disease
A multidisciplinary Oncology Board focused on a challenging recurrent NSCLC case, treatment decisions after multiple lines of therapy, and evidence-based multidisciplinary care.
- Evaluation of isolated nodal recurrence
- Local versus systemic treatment strategies
- Repeat biopsy and molecular testing
- Selection of next-line systemic therapy